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Abstract
Understanding the mechanism behind drugs of abuse is one of the key elements to
understanding why addiction is so prevalent in society. The goal of this research was to
determine the effect that a popular cannabinoid, Δ -9-tetrahydrocannabinol has on the
regulation of dopamine neurotransmitter in the synapses. It was hypothesized that the
addictive high users experience from using Δ-9-THC had a direct effect on lowering the
dopamine transporter protein on cell surface causing a buildup of dopamine in the
synapse. The results of the study show that the higher concentration of Δ-9-THC that the
cells were exposed to caused a fewer amount of dopamine transporter protein to be
present on the cell surface. This decreased cell surface dopamine transporter could result
in less dopamine re-uptake from the synapses and a prolonged dopamine existence in the
synapses
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1.0 Introduction
Dopamine is a neurotransmitter that plays a major role in drug addiction. The
central pharmacological and molecular mechanism of all drugs of abuse associated with
addiction is on the reward circuit of the brain which is the brain's pleasure center. The
most important reward circuit in the brain is the mesolimbic dopamine system which
consists of three main areas: the ventral tegmental area (VTA), the nucleus accumbens,
and the prefrontal cortex. The mesolimbic dopamine system is the neurological system
using dopamine as neurotransmitter that plays a central role in drug addiction. Dopamine
has been linked to the reward system, including feelings of motivation and emotion
(Chen, Furman, & Gnegy 2010). Many illegal drugs try to mimic the effects produced by
naturally occurring dopamine by interacting with the dopaminergic pathways. This is
because the drug reward circuitry is primarily revolved around the mesolimbic dopamine
system (Tebbett, 2007). Prolonged stimulation of dopaminergic signaling network will
cause euphoric effect and addiction. The abusive drugs can excite the dopaminergic
signaling network via two different major mechanisms: (1) increasing dopamine release
into synapses to activate reward circuit and (2) inhibiting the dopamine clearance from
synapses. Either of these two mechanisms has an ultimate result in excess amounts of
dopamine molecules in the synapse. Build up of dopamine in the synapse causes
physical symptoms such as euphoria, increased motor activity, and psychotic symptoms.
One protein that has a great impact on synaptic dopamine clearance is dopamine
transporter (DAT). The main function of DAT is to re-uptake the synaptic dopamine back
into pre-synaptic neurons. It is well known that stimulants, such as cocaine and
amphetamines, interact directly with the dopamine transporter with different

	
   2	
  
mechanisms. Cocaine has the ability to stimulate pleasure centers by inhibiting the
dopamine transporter. Amphetamines act as dopamine transport substrates that are in
competition with dopamine, which is sought to be transported. Amphetamines enter
dopamine neurons and stimulate the internalization of DAT (Wheeler et al., 2014). This
class of drugs is able to produce this mechanism due to the strong similarities in the
molecular structure between amphetamines and dopamine. The internalization process of
the dopamine transporter is known as endocytosis. It is hypothesized that this mechanism
of dopamine transporter endocytosis is employed by another class of drugs known as
cannabinoids.
Δ -9-Tetrahydrocannabinol is the primary psychoactive drug in the popular plant
drug marijuana, a member of the drug class of cannabinoids. This drug is becoming more
and more prevalent in society due to its legalization in some of the United States and also
for its medicinal uses (Lupica, Riegel, & Hoffman, 2004). Despite the growing popularity
of Δ -9-tetrahydrocannabinol, the mechanism behind the high that users feel when
smoking marijuana is not one that is well established. There is some belief that Δ -9-THC
is able to interact with the dopamine transporter in a similar way as stimulant drugs. This
study was performed to determine the effect that Δ -9-THC has on the dopamine
transporter proteins on the cell surface. It is hypothesized that the use of Δ -9-THC has
the ability to regulate the trafficking of the dopamine transporter from and to the cell
surface. Because of the decreased function of the dopamine transporter, this results in
buildup of dopamine neurotransmitter in the synapse. The buildup of dopamine in the
synapse causes the high that users experience and increases the addictive nature of the
drug.
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In the past, a study had been done to observe the effect of Δ -9-THC on the
dopamine releasers and transporters in Rhesus monkeys. In this study, the monkeys were
administered the drug and withdrawal was measured by observing the head shaking
behavior. (Schulze et al.,2012) This head shaking behavior was defined as the rapid
movement of the monkey’s head from side to side. The conclusions of this study showed
that dopamine release and inhibition of the dopamine transporter block the detection of Δ
-9-THC and enhance the subjective effects of marijuana withdrawal. (Schulze, Carroll, &
Mcmahon, 2012) This study contributes to the hypothesis that reduction of dopamine
transporter activity results in enhanced addictive properties of marijuana and other
cannabinoids.
Identifying the mechanism that is responsible for the high the cannabinoid users
experience from Δ-9-THC could be extremely beneficial to the field of forensic science
because it could provide a biological mechanism to support the addiction users
experience. The underlying mechanism of the drug interaction with the dopamine
transporter should ultimately be determined to provide possible explanations for addictive
properties of drugs of abuse.
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2.0 Materials and Methods:
This experiment was performed using human embryonic kidney (HEK) cells
which were stable transfected with the human dopamine transporter (HEKDAT) in the
completed media consisting of Dulbecco's modified eagle medium (DMEM), 10% fetal
bovine serum (FBS), G418 (500 µg/ml) as a selective agent, and gentamicin (50 µg/ml).
These cells were obtained from Dr. Reith at New York University, School of Medicine.
Once the cells had grown, the cells were then sub-cultured into nine 60mm Petri dishes
for experiments. The Petri dishes were placed in an incubator at 37 o C and 5% CO2.
2.1 Western blot
The following steps in were employed to obtain analysis of the quantity of DAT
on the cell surface through Western blot.
2.1.1 Chemical treatment:
The chemical used to treat the HEK-DAT cells is Δ-9-THC 1 mg/mL in methanol
solution from Cerilliant. Treatment solutions of the following concentrations were made
through dilutions with phosphate buffered saline (PBS) from the stock: 0.0µg/mL,
0.02µg/mL, 0.2µg/mL, 0.5µg/mL, 1µg/mL, 5µg/mL, 10µg/mL, 25 µg/mL, and 50
µg/mL. The cells were treated with the chemicals in varying concentrations and allowed
to incubate at 37 o C for one hour.
2.1.2 Biotinylation:
In order to isolate the cell surface proteins, proteins on the cell surface were
labeled by biotin first. Following chemical treatment, the drug was removed from the
Petri dishes and the cells were washed with cold PBS/0.1 mM CaCl2/0.1 mM MgCl2
(PBS-CM) three times. Sulfo-NHS-SS-biotin (1 mg/mL) in PBS-CM was added to the
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cells and allowed to incubate for one hour at 4 oCelsius. The cells were then washed twice
with PBS-CM supplemented with 100 mM Glycine two times and incubated with this
buffer for 20 minutes on ice. Following incubation, the cells were washed with PBS three
times.
2.1.3 Cell Lysis:
The next step in the procedure is the lysing of the cells. 1 mL of MammalianProtein Extraction Reagent with protease inhibitor cocktail from Pierce was added to
each sample, gently shaken for 10 minutes at 20 o C. The cells were then kept on ice and
vortexed 13 times over a 60- minute interval. The samples were then centrifuged at
14,000 g for 15 minutes at 4 o C. The supernatant was transferred to a new tube.
2.1.4 Protein Assay:
A protein assay using Bio-Rad DC protein assay was performed to determine the
concentration of samples. After concentration calculation, the samples were used to
prepare two other sets of samples: (1) 15 µg of total proteins from each sample were used
for the detection of the total DAT; (2) 200 µg of proteins from each sample was used in
the next part of the experiment for the isolation of biotinylated proteins.
2.1.5 Isolation of biotinlyated cell surface proteins:
NeutraAvidin agarose resin was suspended and washed with PBS to obtain 50%
(v/v) agarose resin solution. 100 µL of NeutraAvidin agarose resin solution was added to
the spin column. Lysed samples in concentration of 200 µg were added to the spin
column. The samples were shaken for 2 hours at room temperature. After shaking, the
bottom of the spin column was cut off and the column was placed into a collection tube.
The tube was centrifuged at 8,000 rpm for 5 seconds. The flow through is non-
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biotinylated protein which is discarded. A series of washes were done to the resin. The
first wash consisted of three wash steps with cold PBS at 500 µl per wash. The second
wash was repeated twice with 500 µl of cold High Salt wash buffer (500 mM NaCl, 50
mM Tris pH 7.5). The third wash was performed once with 500 µl of No Salt wash buffer
(50 mM Tris pH 7.5). The bottom cap was then placed on the spin column. 75 µL of
Dithiothreitol-Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (DTT-SDSPAGE) sample buffer was added to each column to elute the biotinylated cell surface
proteins. The columns were incubated for 10 minutes at room temperature and 40
minutes at 37 o C. After incubation, the columns were centrifuged at 8000 rpm for 2
minutes. The eluent is the biotinylated proteins. The samples were then stored at -20
degrees Celsius for western blot analysis.
2.1.6 SDS-PAGE and Western Blot:
A set of two 8% acrylamide gels were prepared. The eluted samples from the
biotinylated protein isolation were loaded onto one gel with protein standard mixture.
Total proteins (15 µg) from each sample were loaded onto the second gel with protein
standard mixture. The gels were allowed to run for 1.5 hours at 100V. The separated
protein samples were then transferred from the gel to a polyvinylidene difluoride,
(PVDF) membrane overnight (22-24 hours) at 18V in the cold room.
The membranes were then blocked in 5% bovine serum albumin (BSA) in wash
buffer for 1 hour at room temperature with shaking. Primary antibody against human
DAT (1 µg/µL) in 1% BSA/wash buffer was applied to membranes and incubated in cold
room for overnight with shaking. After washing with wash buffer, membranes were
incubated with the secondary antibody which is conjugated with horseradish peroxidase
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for 1 hour at room temperature with shaking. Chemiluminescent signals were detected
after extensive washes by wash buffer.
2.1.7 Detection
SuperSignal™ West Pico PLUS Chemiluminescent Substrate from Thermo
Scientific was applied to membranes. Detection was performed by measuring the
intensity of light emitted by each band on the membrane. The signal detected for each
biotinylated DAT sample was evaluated as a ratio to the corresponding signal detected on
the membrane for the total DAT. The control results were then taken as 1.
2.2. Immunocytochemistry
To visualize the location of the dopamine transporter protein on the HEK-DAT
cells, immunocytochemistry methods were employed using the following procedure.
2.2.1 Chemical treatment
HEK-DAT cells were grown in the same media as previously mentioned. The
cells were then transferred to glass microscope chamber slides that contained four
separated wells. An equal concentration of cells (~2x104 cells per well) was distributed
evenly among the wells and allowed to incubate overnight an incubator at 37 o C and 5%
CO2. The same chemical treatment regime was applied to the cells on the glass
microscope chamber slides. The chemical used to treat the HEK-DAT cells is Δ-9-THC 1
mg/ml in methanol solution from Cerilliant. Treatment solutions of the following
concentrations were made through dilutions with PBS from the stock: 0.0µg/mL,
0.02µg/mL, 0.2µg/mL, 0.5µg/mL, 1µg/mL, 5µg/mL, 10µg/mL, 25 µg/mL, and 50
µg/mL. Each microscope slide contained a negative control (0.0µg/mL solution of THC)
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in the first well. The cells were treated with the chemical for 60 minutes and then the
chemical solution was removed.
2.2.2 Antibody Treatment
Once the chemical treatment was removed, each well was washed with PBS.
Next, the cells of each well were fixed by the application of 3.7% formaldehyde in PBS.
The cells were incubated in the formaldehyde solution for 15 minutes and then the
solution was removed. After the cells had been fixed and washed by PBS, a blocking
solution of 5% Bovine Serum Albumin/ PBS/ 0.05% Tween 20 was applied for 1 hour.
Next a series of antibodies was applied to each well. The primary antibody, anti-DAT
rabbit polyclonal igG (Santa Cruz Biotechnology, USA) (0.3 µg/mL in 1% BSA in
PBS/0.05% Tween 20) was applied to the cells and incubated over night at 4 degrees
Celcius. After removal of the primary antibody, incubation with Alexa Fluor 488
conjugated goat anti rabbit (excitation wavelength 488 and emission 510 nm) secondary
antibody diluted 1:500 in 1% BSA in PBS/0.05% Tween 20 occurred for 1 hour at room
temperature.
2.2.3 Mounting and Visualization of Cells
After antibody treatments and washing, the slides were mounted with Prolong
Gold antifade Reagent (Invitrogen) for 24 hours and then were sealed using clear nail
polish. Slides were then examined with the fluorescent Nikon Eclipse E600 microscope
at various magnifications.
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3.0 Results
3.1 Western Blot Analysis
Using the results determined by the amount of fluorescence emitted by each band
on the membrane, a ratio was calculated for each concentration of Δ-9-THC that was
employed. The amount of fluorescence emitted by the band on the membrane which
contained the biotinylated DAT was divided by the amount of the fluorescence emitted
by the band on the membrane which contained the total DAT. This calculation provided
the ratio of the number of biotinylated DAT molecules to the total amount of DAT
molecules present on the cell surface. The ratio was then graphed against the
concentration of Δ-9-THC that was applied to the cells to observe the effect of Δ-9-THC
on the number of cell surface dopamine molecules. The results are displayed in Figure 1.
The graph displays that as the concentration of Δ-9-THC increased the

amount of

biotinylated DAT decreases. For the concentration of 10 µg/mL, the ratio was
significantly higher than expected and did not follow the trend of the data. It is expected
ratio of biotinylated DAT to total DAT for cells treated with 10 ug/mL would be less than
the ratio of biotinylated DAT to total DAT for 5 ug/mL. Cells treated with 50 ug/mL
have significant less percentage of DAT on surface as compared with control cells (0
ug/mL).
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Figure 1. The relationship between the concentrations of THC applied to the cells is displayed versus
the ratio of biotinylated DAT to total DAT. *p <0.05 vs. control group (0 µg/mL)

3.2 Immunocytochemistry Analysis
The results of the immunocytochemistry experiment were successful in being able
to determine the location of the DAT in the cell. Figures 2-5 displays the images obtained
using fluorescent Nikon E-600 microscope at 40X magnification. DAPI was applied to
cells for staining the double strain DNA by associating with AT clusters in the minor
groove of DNA. DAPI is a popular nuclear blue fluorescent counterstain was used to
localize the nuclei of cells. (Larsson, A., Åkerman, B., & Jonsson, M. (1996) Since cells
were not treated with detergent during the staining process, DAT green fluorescent
images show the expression of cell surface DAT. The results in Figure 2 display DAT
expressed on cell surfaces. With 10 µg/mL Δ-9-THC exposure (Figure 3), DAT cell
surface expression did not show a decrease when compared with control samples. In
Figure 4 which cells were treated 25 µg/mL Δ-9-THC, cells showed less cell surface
DAT with hollow circles in the center of cells. The morphology of cells treated with 25
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µg/mL Δ-9-THC was changed with irregular cell shapes (Figure 4). Cells treated with 50
µg/mL Δ-9-THC (Figure 5) showed very similar characteristics as cells treated with 25
µg/mL Δ-9-THC (Figure 4). These results were critical to the visualization of DAT
located on the cell.

Figure 2. The fluorescent images of control cells stained with DAPI in blue fluorescence and immuneprobed with DAT in green fluorescence. (40X)

Figure 3. The fluorescent images of 10 µg/mL Δ-9-THC treated cells stained with DAPI in blue
fluorescence and immune-probed with DAT in green fluorescence. (40X)
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Figure 4. The fluorescent images of 25 µg/mL Δ-9-THC treated cells stained with DAPI in blue
fluorescence and immune-probed with DAT in green fluorescence. (40X) The solid white arrows
point to the hollow circles of the cells. The dashed arrows point to the cells with irregular
morphology.

Figure 5. The fluorescent images of 50 µg/mL Δ-9-THC treated cells stained with DAPI in blue
fluorescence and immune-probed with DAT in green fluorescence.(40X) The solid white arrows point
to the hollow circles of the cells. The dashed arrows point to the cells with irregular morphology.
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4.0 Discussion
This experiment demonstrates the effects that Δ-9-THC exhibited on the cell
surface dopamine transporter expression in HEK cells. The results of both western blot
analysis and immunocytochemistry show that there is a decreased amount of cell surface
dopamine transporter protein with increased Δ-9-THC concentrations. Because the
transporter is located within the cell membrane to facilitate dopamine re-uptake, reducing
DAT expression on cell surface will lead to dopamine molecules build up in the synapse
with no way of being transported back inside the cell. The prolonged exposure to the
build-up of dopamine in the synapse can be one of the main contributions to why the
cannabinoid drug has strong addictive properties.
There are three different possible mechanisms as to why the number of DAT
molecules on the cell surface were decreased in this experiment. All of these explanations
are driven from all of the possible interactions that can occur between the drug, Δ-9-THC
and the dopamine transporter. The possible methods for the change DAT cell surface
expression are: 1) deceased trafficking of DAT from inside the cell to the cell surface, 2)
increased DAT-inhibition reactions 3) internalization of the DAT molecule. Because the
experiment was conducted on a single exposure of drug to the cells, it is still unclear
which on the methods were observed to reduce the number of DAT molecules on the cell
surface. Through the results of this experiment, it can be determined that Δ-9-THC does
have the ability to interaction with the dopamine reward circuit pathway by means of the
dopamine transporter.

	
   14	
  
Conclusion:
The data collected through both analytical methods used, western blot and
immunocytochemistry, support the hypothesis that the cannabinoid Δ-9-THC does
interact with the dopamine transporter protein. It can be further implied that the addictive
nature of the drug can be attributed with its ability to interact and alter the brain’s natural
dopamine reward circuit. Although the specific mechanism of interaction between Δ-9THC and the dopamine transporter was not determined, it is proven that higher
concentrations of the drug the cells were exposed to resulted in a lower concentration of
dopamine transporter protein located on the cell surface.
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